|
Market Closed -
Euronext Paris
11:55:00 2026-11-06 EST
|
Pre-market 01:43:13 | |||
| 27.00 EUR | -1.03% |
|
27.42 | +1.56% |
| 10-26 | Analysts unanimous after Nanobiotix's NBTXR3 results |  |
| 10-26 | Nanobiotix unveils encouraging results in the treatment of advanced melanoma | |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NANOBIOTIX | Other Biotechnology & Medical Research | -1.03% | -3.98% | +38.46% | +58.64% | +204.91% | 1.53B |  |  | |
- Stock Market
- Stocks
- NANO Stock
- Charts Nanobiotix
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
